Section Arrow
Quote
BJDX.NASDAQ
- Bluejay Diagnostics Inc.
Quotes are at least 15-min delayed:2026/04/26 01:54 EDT
Regular Hours
Last
 1.8988
-0.061 (-3.11%)
Day High 
1.9591 
Prev. Close
1.9598 
1-M High
2.13 
Volume 
6.84K 
Bid
1.72
Ask
1.99
Day Low
1.8988 
Open
1.94 
1-M Low
1.649 
Market Cap 
2.03M 
Currency 美元 
P/E 0 
%Yield -- 
10-SMA 1.92 
20-SMA 1.93 
50-SMA 2.03 
52-W High 16.68 
52-W Low 1.649 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-15.25/-0.29
Enterprise Value
2.05M
Balance Sheet
Book Value Per Share
5.77
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.